These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 14971153)

  • 1. [Antiphospholipid activity of the blood in patients with ischemic heart disease and thrombogenic complications].
    Shashilina LV; Urazgil'deeva SA; Mnuskina MM; Oganesian LV; Makarova IN; Gurevich VS
    Klin Med (Mosk); 2003; 81(12):30-2. PubMed ID: 14971153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ocular thrombosis associated with antiphospholipid antibodies.
    Galetta SL; Plock GL; Kushner MJ; Wyszynski RE; Brucker AJ
    Ann Ophthalmol; 1991 Jun; 23(6):207-12. PubMed ID: 1746813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resistance to annexin A5 anticoagulant activity: a thrombogenic mechanism for the antiphospholipid syndrome.
    Rand JH; Wu XX; Quinn AS; Taatjes DJ
    Lupus; 2008 Oct; 17(10):922-30. PubMed ID: 18827057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The immunology of atherothrombosis in the antiphospholipid syndrome: antigen presentation and lipid intracellular accumulation.
    Matsuura E; Kobayashi K; Matsunami Y; Lopez LR
    Autoimmun Rev; 2009 May; 8(6):500-5. PubMed ID: 19171205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The antiphospholipid syndrome and heart valve surgery.
    Gorki H; Malinovski V; Stanbridge RD
    Eur J Cardiothorac Surg; 2008 Feb; 33(2):168-81. PubMed ID: 18082413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Antiphospholipid syndrome and changes in the eye].
    Gerkowicz M; Latalska M; Kosior-Jarecka E; Kozioł-Montewka M; Pietraś-Trzpiel M
    Klin Oczna; 2005; 107(1-3):143-6. PubMed ID: 16052828
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Methods of prevention of ischemic cerebral damages in patients with antiphospholipid antibodies].
    Roşca T
    Oftalmologia; 2008; 52(2):72-6. PubMed ID: 19065918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiphosphatidylethanolamine antibodies and the antiphospholipid syndrome.
    Sanmarco M; Boffa MC
    Lupus; 2009 Sep; 18(10):920-3. PubMed ID: 19671793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiphospholipid syndrome and asymptomatic carriers of antiphospholipid antibody: prospective analysis of 404 individuals.
    Girón-González JA; García del Río E; Rodríguez C; Rodríguez-Martorell J; Serrano A
    J Rheumatol; 2004 Aug; 31(8):1560-7. PubMed ID: 15290736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiphospholipid antibodies bind to activated but not resting endothelial cells: is an independent triggering event required to induce antiphospholipid antibody-mediated disease?
    Chen Q; Stone PR; Woon ST; Ching LM; Hung S; McCowan LM; Chamley LW
    Thromb Res; 2004; 114(2):101-11. PubMed ID: 15306152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Revisiting antiphospholipid antibodies: from targeting phospholipids to phospholipid binding proteins.
    Bertolaccini ML; Hughes GR; Khamashta MA
    Clin Lab; 2004; 50(11-12):653-65. PubMed ID: 15575307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Antiphospholipid syndrome--specificity of antiphospholipid antibodies and thrombosis].
    Kaburaki J
    Nihon Rinsho Meneki Gakkai Kaishi; 1999 Feb; 22(1):1-12. PubMed ID: 11185686
    [No Abstract]   [Full Text] [Related]  

  • 13. [Antiphospholipid syndrome and pregnancy].
    Koleva R; Chernev T; Karag'ozova Zh; Dimitrova V
    Akush Ginekol (Sofiia); 2004; 43(1):36-42. PubMed ID: 15168653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Primary antiphospholipid syndrome].
    Popa A; Voinea L; Pop M; Stana D; Dascalu AM; Alexandrescu C; Ciuluvica R
    Oftalmologia; 2008; 52(1):13-7. PubMed ID: 18714484
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiphospholipid antibody tests: spreading the net.
    Bertolaccini ML; Gomez S; Pareja JF; Theodoridou A; Sanna G; Hughes GR; Khamashta MA
    Ann Rheum Dis; 2005 Nov; 64(11):1639-43. PubMed ID: 15817655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Need for additional trials of primary prophylaxis in patients with high-risk antiphospholipid antibody profiles: comment on the article by Erkan et al.
    Wahl D; Lecompte T; Bounameaux H
    Arthritis Rheum; 2008 Feb; 58(2):635-6; author reply 636. PubMed ID: 18240250
    [No Abstract]   [Full Text] [Related]  

  • 17. Risk factors for a first thrombotic event in antiphospholipid antibody carriers. A multicentre, retrospective follow-up study.
    Ruffatti A; Del Ross T; Ciprian M; Nuzzo M; Rampudda M; Bertero MT; Bergia R; Caramaschi P; Biasi D; Capsoni F; Montaguti L; Ruffini R; Brucato A; Picillo U; Fanelli V; Riccieri V; Piccoli A; Valesini G; Doria A; Meroni PL; Tincani A
    Ann Rheum Dis; 2009 Mar; 68(3):397-9. PubMed ID: 18812393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Antiphospholipid antibodies with HCV infection. Innocent proteins or risk factor?].
    Kisiel E; Kryczka W
    Przegl Lek; 2007; 64(7-8):521-4. PubMed ID: 18409357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical performance (sensitivity and agreement with thrombosis) of four antiphospholipid antibody assays.
    Lopez LR; Whittier AM; Dier KJ; Taylor DO; Buckner TR; Olsen LW; Fink CA
    Am Clin Lab; 2002 Apr; 21(3):41-4. PubMed ID: 12038085
    [No Abstract]   [Full Text] [Related]  

  • 20. Is there an association between complement activation and antiphospholipid antibody-related thrombosis?
    Devreese KM; Hoylaerts MF
    Thromb Haemost; 2010 Dec; 104(6):1279-81. PubMed ID: 20838748
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.